Skip to main content

Computational Approach in Designing and Development of Novel Inhibitors of AKR1C1

  • Conference paper
  • First Online:
Ambient Intelligence in Health Care

Abstract

Aldo-keto reductase family 1 member C1 otherwise recognized as dihydrodiol dehydrogenase 1/2 is an enzyme encoded as AKR1C1 gene in humans. The increased expression of AKR1C1 in oncogenesis is resistant to several anticancer agents for which a lot of research is going on with this enzyme to design and develop new and effective anticancer drugs. In the present work, with the help of 60 AKR1C1 inhibitor dataset, models were designed for pIC50(M) end points based on quantitative structure activity relationship. Molecular docking was also carried out for the AKR1C1 gene, to identify the residues responsible for the inhibition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ji, Q., Aoyama, C., Nien, Y.-D., Liu, P.I., Chen, P.K., Chang, L., Stanczyk, F.Z., Stolz, A.: Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res. 64, 7610–7617 (2004)

    Article  Google Scholar 

  2. Kapetanović, I.: Drug Discovery and Development: Present and Future. BoD—Books on Demand (2011)

    Google Scholar 

  3. Gilson, M.K., Liu, T., Baitaluk, M., Nicola, G., Hwang, L., Chong, J.: BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 44, D1045–D1053 (2016). https://doi.org/10.1093/nar/gkv1072

    Article  Google Scholar 

  4. Gramatica, P., Chirico, N., Papa, E., Cassani, S., Kovarich, S.: QSARINS: a new software for the development, analysis, and validation of QSAR MLR models. J. Comput. Chem. 34, 2121–2132 (2013). https://doi.org/10.1002/jcc.23361

    Article  Google Scholar 

  5. Veerasamy, R., Rajak, H., Jain, A., Sivadasan, S., Varghese, C.P., Agrawal, R.K.: Validation of QSAR models-strategies and importance. Int. J. Drug Des. Discov. 3, 511–519 (2011)

    Google Scholar 

  6. Golbraikh, A., Tropsha, A.: Beware of q2! J. Mol. Graph. Model. 20, 269–276 (2002)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Ganga Raju Achary .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Das, N.R., Sharma, T., Mallick, A., Toropova, A.P., Toropov, A.A., Achary, P.G.R. (2023). Computational Approach in Designing and Development of Novel Inhibitors of AKR1C1. In: Swarnkar, T., Patnaik, S., Mitra, P., Misra, S., Mishra, M. (eds) Ambient Intelligence in Health Care. Smart Innovation, Systems and Technologies, vol 317. Springer, Singapore. https://doi.org/10.1007/978-981-19-6068-0_32

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-6068-0_32

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-6067-3

  • Online ISBN: 978-981-19-6068-0

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics